Skip to main content
Earnings Labs
Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ·Healthcare·Biotechnology

$38.83

+3.74%

Mkt Cap $681.06M

Analyst Ratings

Buy

5

Hold

0

Sell

0

Price Target (4 analysts)

$27.33

Range $2.00$42.00

Implied Upside

-29.6%

Consensus $27.33 vs current $38.83